• Afinum agreed to sell STG Swiss Technology Group to TTM Technologies alongside other minority investors.
• STG makes micro-scale printed circuits for medical devices, using proprietary semi-additive process technology enabling circuit geometries down to 10µm.
• STG expanded revenue and profitability under Afinum’s ownership, shifting further toward higher-growth MedTech end markets.
• The group added plating and surface finishing via Hofstetter in 2023, followed by Gramm in 2025.
• Closing is expected in Q3 2026, subject to regulatory approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Afinum Management GmbH published the original content used to generate this news brief on June 18, 2026, and is solely responsible for the information contained therein.